000 01473 a2200421 4500
005 20250513110831.0
264 0 _c19970204
008 199702s 0 0 eng d
022 _a0003-4975
024 7 _a10.1016/s0003-4975(96)00743-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoen, O
245 0 0 _aAttenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass.
_h[electronic resource]
260 _bThe Annals of thoracic surgery
_cJan 1997
300 _a105-11 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, Surface
_xmetabolism
650 0 4 _aBiocompatible Materials
650 0 4 _aCardiopulmonary Bypass
_xadverse effects
650 0 4 _aComplement Activation
650 0 4 _aCoronary Artery Bypass
650 0 4 _aFemale
650 0 4 _aHeparin
650 0 4 _aHumans
650 0 4 _aLeukocyte Count
650 0 4 _aLymphocyte Activation
650 0 4 _aMale
650 0 4 _aPlatelet Count
700 1 _aHøgåsen, K
700 1 _aFosse, E
700 1 _aDregelid, E
700 1 _aBrockmeier, V
700 1 _aVenge, P
700 1 _aHarboe, M
700 1 _aMollnes, T E
773 0 _tThe Annals of thoracic surgery
_gvol. 63
_gno. 1
_gp. 105-11
856 4 0 _uhttps://doi.org/10.1016/s0003-4975(96)00743-6
_zAvailable from publisher's website
999 _c8984628
_d8984628